Medical devices in Bulgaria: Regulatory framework, market dynamics, and institutional development

Bulgaria occupies a unique position among European Union member states, with the lowest per capita healthcare expenditure (€990 annually) yet demonstrating the second-highest growth rate in health spending between 2014 and 2022. This economic paradox reflects the dynamics of a developing market operating under resource constraints while facing growing needs from an aging population. The medical devices sector is an essential component of Bulgaria‘s healthcare system, including products ranging from simple consumables to sophisticated implantable devices and advanced diagnostic equipment. This review examines the Bulgarian medical device landscape through multiple dimensions: historical evolution from medieval surgical instruments to contemporary AI-integrated systems, fundamental distinctions from pharmaceuticals and dietary supplements based on mechanisms of action, the comprehensive regulatory framework under Medical Device Regilation (MDR) 2017/745, institutional interactions among key organizations (the Bulgarian Drug Agency, the National Health Insurance Fund, the Ministry of Health), and market trends shaped by demographic transformation. With a population of 6.44 million (23.8% over 65 years), Bulgaria faces pressing demographic challenges that reshape healthcare demand patterns. The analysis reveals a market exceeding €300 million, dependent on imports (>90%), with limited domestic manufacturing capacity. Despite the financial constraints, Bulgaria has achieved an international recognition through top-tier regulatory inspections and active participation in the European regulatory structures. The review outlines perspectives for short-term priorities (2025–2027), medium-term objectives (2027–2030), and long-term vision (2030+) for sector development, emphasizing the digital transformation, regional coverage improvement, and demographic crisis management through the technological innovation.